Synthomer (LON:SYNT) Issues Quarterly Earnings Results

Synthomer (LON:SYNTGet Free Report) released its quarterly earnings results on Wednesday. The company reported GBX (3.50) (($0.05)) EPS for the quarter, Digital Look Earnings reports. Synthomer had a negative net margin of 4.40% and a negative return on equity of 7.52%.

Synthomer Price Performance

Shares of SYNT stock traded up GBX 6.60 ($0.09) on Friday, reaching GBX 121 ($1.57). 1,620,407 shares of the company were exchanged, compared to its average volume of 658,803. The business has a 50-day moving average price of GBX 139.90 and a 200 day moving average price of GBX 171.16. Synthomer has a 1 year low of GBX 114 ($1.48) and a 1 year high of GBX 338 ($4.38). The company has a debt-to-equity ratio of 78.27, a quick ratio of 0.97 and a current ratio of 1.90. The company has a market cap of £198.41 million, a price-to-earnings ratio of -2.42, a P/E/G ratio of -0.17 and a beta of 1.79.

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank cut Synthomer to a “hold” rating and dropped their target price for the company from GBX 230 ($2.98) to GBX 150 ($1.94) in a research report on Wednesday.

Read Our Latest Stock Report on SYNT

About Synthomer

(Get Free Report)

Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.

Read More

Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.